Summary
Latest filing:
Samuel P. Sears Jr. is Director of Inhibitor Therapeutics, Inc. (INTI). 2 SEC Form 4 filings on record going back to 2025, most recently on 4 August 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Samuel P. Sears Jr. has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Samuel P. Sears Jr.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GIC Private Ltd - $812.73M of MDLN open-market activity in the last 12 months
- Martine A. Rothblatt - $750.95M of UTHR open-market activity in the last 12 months
- TPG GP A, LLC - $742.97M of LFST open-market activity in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M of SHC open-market activity in the last 12 months
- Keith A. Meister - $591.13M of ILMN open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Samuel P. Sears Jr.?
Samuel P. Sears Jr. is a corporate insider, tracked as Director of Inhibitor Therapeutics, Inc. (INTI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Samuel P. Sears Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Samuel P. Sears Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Samuel P. Sears Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
